| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.0009 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |